Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
about
Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@en
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@nl
type
label
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@en
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@nl
prefLabel
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@en
Circulating SCCA-IgM complex i ...... tocellular carcinoma patients.
@nl
P2093
P2860
P50
P1476
Circulating SCCA-IgM complex i ...... atocellular carcinoma patients
@en
P2093
Concetta Tuccillo
Filomena Morisco
Francesco Auriemma
Giorgio Fassina
Laura Paneghetti
Nicola Caporaso
Raffaella Tortora
P2860
P304
P356
10.1080/00365513.2017.1336569
P577
2017-06-13T00:00:00Z